Accumulation of β-amyloid fibrils in pancreas of transgenic mice

Takeshi Kawarabayashi, Mikio Shoji, Masahiro Sato, Atsushi Sasaki, Libin Ho, Christopher B. Eckman, Christian Mihail Prada, Steven G Younkin, Takashi Kobayashi, Norihiro Tada, Etsuro Matsubara, Tomomichi Iizuka, Yasuo Harigaya, Kazuhiro Kasai, Shunsaku Hirai

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Some forms of familial Alzheimer's disease are caused by mutations in the amyloid β protein precursor (βAPP), and there is excellent evidence that these mutations foster amyloid deposition by increasing secretion of total amyloid β protein (Aβ) or the highly amyloidogenic Aβ1-42 form. These observations provide a powerful rationale for developing an animal model of AD by generating transgenic mice in which cerebral amyloid deposition is induced by Aβ overproduction. To produce substantial Aβ in vivo, we generated mice expressing the transgene of signal peptide and 99 residues of carboxyl-terminal fragment (CTF) of βAPP under control of the cytomegalovirus enhancer/chicken β-actin promoter. The transgenic mRNA was detected in many tissues of these mice, bur the levels of transgenic mRNA, CTF, and Aβ did not correlate well indicating that tissue-specific posttranslational processing may play an important role in determining the amount of Aβ that accumulates in various tissues. Aβ was detected biochemically in brain, kidney, and pancreas with the largest amount present in pancreas. In transgenic plasma, there was a marked accumulation of human Aβ1-40 and Aβ1-42(43) to levels over 30-times those observed in normal human plasma. Thus, the transgenic mice produce and secrete considerable Aβ. Despite this increase in Aβ secretion and the elevated Aβ in brain, immunohistochemistry revealed no consistent cerebral Aβ deposition. In pancreas, however, intracellular Aβ deposits were detected immunohistochemically in acinar cells and interstitial macrophages, some of which showed severe degeneration. In addition, examination of these cells by immunoelectron microscopy revealed many putative amyloid fibrils (7-12 nm) that were stained by anti-Aβ antibodies. Overall, our findings indicate that tissue-specific posttranslational processing may play a pivotal role in Aβ production and amyloid fibril formation in vivo. By carefully analyzing the changes that occur in the transgenic mice described here as compared to the transgenic line that has recently been shown to form extracellular amyloid plaques in brain, it may be possible to gain considerable insight into the factors that determine the location and amount of Aβ that accumulates as amyloid.

Original languageEnglish (US)
Pages (from-to)215-222
Number of pages8
JournalNeurobiology of Aging
Volume17
Issue number2
DOIs
StatePublished - Mar 1996
Externally publishedYes

Fingerprint

Amyloid
Transgenic Mice
Pancreas
Amyloid beta-Protein Precursor
Brain
Serum Amyloid A Protein
Messenger RNA
Mutation
Immunoelectron Microscopy
Acinar Cells
Amyloid Plaques
Protein Sorting Signals
Cytomegalovirus
Transgenes
Actins
Anti-Idiotypic Antibodies
Chickens
Alzheimer Disease
Animal Models
Immunohistochemistry

Keywords

  • β-actin promoter
  • Alzheimer's disease
  • Amyloid β protein
  • Amyloid β protein precursor
  • Amyloid fibrils
  • Carboxyl-terminal fragment
  • Pancreas
  • Transgenic mouse

ASJC Scopus subject areas

  • Clinical Neurology
  • Biological Psychiatry
  • Developmental Neuroscience
  • Neurology
  • Psychology(all)

Cite this

Kawarabayashi, T., Shoji, M., Sato, M., Sasaki, A., Ho, L., Eckman, C. B., ... Hirai, S. (1996). Accumulation of β-amyloid fibrils in pancreas of transgenic mice. Neurobiology of Aging, 17(2), 215-222. https://doi.org/10.1016/0197-4580(95)02061-6

Accumulation of β-amyloid fibrils in pancreas of transgenic mice. / Kawarabayashi, Takeshi; Shoji, Mikio; Sato, Masahiro; Sasaki, Atsushi; Ho, Libin; Eckman, Christopher B.; Prada, Christian Mihail; Younkin, Steven G; Kobayashi, Takashi; Tada, Norihiro; Matsubara, Etsuro; Iizuka, Tomomichi; Harigaya, Yasuo; Kasai, Kazuhiro; Hirai, Shunsaku.

In: Neurobiology of Aging, Vol. 17, No. 2, 03.1996, p. 215-222.

Research output: Contribution to journalArticle

Kawarabayashi, T, Shoji, M, Sato, M, Sasaki, A, Ho, L, Eckman, CB, Prada, CM, Younkin, SG, Kobayashi, T, Tada, N, Matsubara, E, Iizuka, T, Harigaya, Y, Kasai, K & Hirai, S 1996, 'Accumulation of β-amyloid fibrils in pancreas of transgenic mice', Neurobiology of Aging, vol. 17, no. 2, pp. 215-222. https://doi.org/10.1016/0197-4580(95)02061-6
Kawarabayashi T, Shoji M, Sato M, Sasaki A, Ho L, Eckman CB et al. Accumulation of β-amyloid fibrils in pancreas of transgenic mice. Neurobiology of Aging. 1996 Mar;17(2):215-222. https://doi.org/10.1016/0197-4580(95)02061-6
Kawarabayashi, Takeshi ; Shoji, Mikio ; Sato, Masahiro ; Sasaki, Atsushi ; Ho, Libin ; Eckman, Christopher B. ; Prada, Christian Mihail ; Younkin, Steven G ; Kobayashi, Takashi ; Tada, Norihiro ; Matsubara, Etsuro ; Iizuka, Tomomichi ; Harigaya, Yasuo ; Kasai, Kazuhiro ; Hirai, Shunsaku. / Accumulation of β-amyloid fibrils in pancreas of transgenic mice. In: Neurobiology of Aging. 1996 ; Vol. 17, No. 2. pp. 215-222.
@article{d61a3131c6af4b11a06a99be4fb48087,
title = "Accumulation of β-amyloid fibrils in pancreas of transgenic mice",
abstract = "Some forms of familial Alzheimer's disease are caused by mutations in the amyloid β protein precursor (βAPP), and there is excellent evidence that these mutations foster amyloid deposition by increasing secretion of total amyloid β protein (Aβ) or the highly amyloidogenic Aβ1-42 form. These observations provide a powerful rationale for developing an animal model of AD by generating transgenic mice in which cerebral amyloid deposition is induced by Aβ overproduction. To produce substantial Aβ in vivo, we generated mice expressing the transgene of signal peptide and 99 residues of carboxyl-terminal fragment (CTF) of βAPP under control of the cytomegalovirus enhancer/chicken β-actin promoter. The transgenic mRNA was detected in many tissues of these mice, bur the levels of transgenic mRNA, CTF, and Aβ did not correlate well indicating that tissue-specific posttranslational processing may play an important role in determining the amount of Aβ that accumulates in various tissues. Aβ was detected biochemically in brain, kidney, and pancreas with the largest amount present in pancreas. In transgenic plasma, there was a marked accumulation of human Aβ1-40 and Aβ1-42(43) to levels over 30-times those observed in normal human plasma. Thus, the transgenic mice produce and secrete considerable Aβ. Despite this increase in Aβ secretion and the elevated Aβ in brain, immunohistochemistry revealed no consistent cerebral Aβ deposition. In pancreas, however, intracellular Aβ deposits were detected immunohistochemically in acinar cells and interstitial macrophages, some of which showed severe degeneration. In addition, examination of these cells by immunoelectron microscopy revealed many putative amyloid fibrils (7-12 nm) that were stained by anti-Aβ antibodies. Overall, our findings indicate that tissue-specific posttranslational processing may play a pivotal role in Aβ production and amyloid fibril formation in vivo. By carefully analyzing the changes that occur in the transgenic mice described here as compared to the transgenic line that has recently been shown to form extracellular amyloid plaques in brain, it may be possible to gain considerable insight into the factors that determine the location and amount of Aβ that accumulates as amyloid.",
keywords = "β-actin promoter, Alzheimer's disease, Amyloid β protein, Amyloid β protein precursor, Amyloid fibrils, Carboxyl-terminal fragment, Pancreas, Transgenic mouse",
author = "Takeshi Kawarabayashi and Mikio Shoji and Masahiro Sato and Atsushi Sasaki and Libin Ho and Eckman, {Christopher B.} and Prada, {Christian Mihail} and Younkin, {Steven G} and Takashi Kobayashi and Norihiro Tada and Etsuro Matsubara and Tomomichi Iizuka and Yasuo Harigaya and Kazuhiro Kasai and Shunsaku Hirai",
year = "1996",
month = "3",
doi = "10.1016/0197-4580(95)02061-6",
language = "English (US)",
volume = "17",
pages = "215--222",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Accumulation of β-amyloid fibrils in pancreas of transgenic mice

AU - Kawarabayashi, Takeshi

AU - Shoji, Mikio

AU - Sato, Masahiro

AU - Sasaki, Atsushi

AU - Ho, Libin

AU - Eckman, Christopher B.

AU - Prada, Christian Mihail

AU - Younkin, Steven G

AU - Kobayashi, Takashi

AU - Tada, Norihiro

AU - Matsubara, Etsuro

AU - Iizuka, Tomomichi

AU - Harigaya, Yasuo

AU - Kasai, Kazuhiro

AU - Hirai, Shunsaku

PY - 1996/3

Y1 - 1996/3

N2 - Some forms of familial Alzheimer's disease are caused by mutations in the amyloid β protein precursor (βAPP), and there is excellent evidence that these mutations foster amyloid deposition by increasing secretion of total amyloid β protein (Aβ) or the highly amyloidogenic Aβ1-42 form. These observations provide a powerful rationale for developing an animal model of AD by generating transgenic mice in which cerebral amyloid deposition is induced by Aβ overproduction. To produce substantial Aβ in vivo, we generated mice expressing the transgene of signal peptide and 99 residues of carboxyl-terminal fragment (CTF) of βAPP under control of the cytomegalovirus enhancer/chicken β-actin promoter. The transgenic mRNA was detected in many tissues of these mice, bur the levels of transgenic mRNA, CTF, and Aβ did not correlate well indicating that tissue-specific posttranslational processing may play an important role in determining the amount of Aβ that accumulates in various tissues. Aβ was detected biochemically in brain, kidney, and pancreas with the largest amount present in pancreas. In transgenic plasma, there was a marked accumulation of human Aβ1-40 and Aβ1-42(43) to levels over 30-times those observed in normal human plasma. Thus, the transgenic mice produce and secrete considerable Aβ. Despite this increase in Aβ secretion and the elevated Aβ in brain, immunohistochemistry revealed no consistent cerebral Aβ deposition. In pancreas, however, intracellular Aβ deposits were detected immunohistochemically in acinar cells and interstitial macrophages, some of which showed severe degeneration. In addition, examination of these cells by immunoelectron microscopy revealed many putative amyloid fibrils (7-12 nm) that were stained by anti-Aβ antibodies. Overall, our findings indicate that tissue-specific posttranslational processing may play a pivotal role in Aβ production and amyloid fibril formation in vivo. By carefully analyzing the changes that occur in the transgenic mice described here as compared to the transgenic line that has recently been shown to form extracellular amyloid plaques in brain, it may be possible to gain considerable insight into the factors that determine the location and amount of Aβ that accumulates as amyloid.

AB - Some forms of familial Alzheimer's disease are caused by mutations in the amyloid β protein precursor (βAPP), and there is excellent evidence that these mutations foster amyloid deposition by increasing secretion of total amyloid β protein (Aβ) or the highly amyloidogenic Aβ1-42 form. These observations provide a powerful rationale for developing an animal model of AD by generating transgenic mice in which cerebral amyloid deposition is induced by Aβ overproduction. To produce substantial Aβ in vivo, we generated mice expressing the transgene of signal peptide and 99 residues of carboxyl-terminal fragment (CTF) of βAPP under control of the cytomegalovirus enhancer/chicken β-actin promoter. The transgenic mRNA was detected in many tissues of these mice, bur the levels of transgenic mRNA, CTF, and Aβ did not correlate well indicating that tissue-specific posttranslational processing may play an important role in determining the amount of Aβ that accumulates in various tissues. Aβ was detected biochemically in brain, kidney, and pancreas with the largest amount present in pancreas. In transgenic plasma, there was a marked accumulation of human Aβ1-40 and Aβ1-42(43) to levels over 30-times those observed in normal human plasma. Thus, the transgenic mice produce and secrete considerable Aβ. Despite this increase in Aβ secretion and the elevated Aβ in brain, immunohistochemistry revealed no consistent cerebral Aβ deposition. In pancreas, however, intracellular Aβ deposits were detected immunohistochemically in acinar cells and interstitial macrophages, some of which showed severe degeneration. In addition, examination of these cells by immunoelectron microscopy revealed many putative amyloid fibrils (7-12 nm) that were stained by anti-Aβ antibodies. Overall, our findings indicate that tissue-specific posttranslational processing may play a pivotal role in Aβ production and amyloid fibril formation in vivo. By carefully analyzing the changes that occur in the transgenic mice described here as compared to the transgenic line that has recently been shown to form extracellular amyloid plaques in brain, it may be possible to gain considerable insight into the factors that determine the location and amount of Aβ that accumulates as amyloid.

KW - β-actin promoter

KW - Alzheimer's disease

KW - Amyloid β protein

KW - Amyloid β protein precursor

KW - Amyloid fibrils

KW - Carboxyl-terminal fragment

KW - Pancreas

KW - Transgenic mouse

UR - http://www.scopus.com/inward/record.url?scp=0029995485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029995485&partnerID=8YFLogxK

U2 - 10.1016/0197-4580(95)02061-6

DO - 10.1016/0197-4580(95)02061-6

M3 - Article

VL - 17

SP - 215

EP - 222

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 2

ER -